Birdwatch Note
2024-04-28 23:21:35 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
For context: This child's name is Ghofran, who is suffering from the rare genetic disorder harlequin ichthyosis. https://www.instagram.com/reel/C6QabJ-O6iS/ https://english.elpais.com/science-tech/2022-07-19/what-is-harlequin-type-ichthyosis-the-strange-fish-skin-disease.html?outputType=amp https://medlineplus.gov/genetics/condition/harlequin-ichthyosis/
Written by 306C6CF8917365FDEC354FA39009BEBB0B3D6440D7E7766D7C38CFB0C7C4E93E
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1784334000384889280
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1784724672447492474
- noteId - 1784724672447492474
- participantId -
- noteAuthorParticipantId - 306C6CF8917365FDEC354FA39009BEBB0B3D6440D7E7766D7C38CFB0C7C4E93E Participant Details
- createdAtMillis - 1714346495151
- tweetId - 1784334000384889280
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- For context: This child's name is Ghofran, who is suffering from the rare genetic disorder harlequin ichthyosis. https://www.instagram.com/reel/C6QabJ-O6iS/ https://english.elpais.com/science-tech/2022-07-19/what-is-harlequin-type-ichthyosis-the-strange-fish-skin-disease.html?outputType=amp https://medlineplus.gov/genetics/condition/harlequin-ichthyosis/
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2024-04-28 23:21:35 UTC (1714346495151) |
2024-04-29 14:44:10 UTC (1714401850430) |
CURRENTLY_RATED_HELPFUL | 2024-05-01 12:35:12 UTC (1714566912495) |
CURRENTLY_RATED_HELPFUL | 2024-04-29 14:44:10 UTC (1714401850430) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
| rated at | rated by | |
| 2024-04-30 12:47:15 -0500 | Rating Details | |
| 2024-04-29 18:35:55 -0500 | Rating Details | |
| 2024-04-29 18:34:36 -0500 | Rating Details | |
| 2024-04-29 12:24:40 -0500 | Rating Details | |
| 2024-04-29 09:43:18 -0500 | Rating Details | |
| 2024-04-29 08:13:36 -0500 | Rating Details | |
| 2024-04-29 07:43:54 -0500 | Rating Details | |
| 2024-04-29 07:38:21 -0500 | Rating Details | |
| 2024-04-29 07:18:22 -0500 | Rating Details | |
| 2024-04-29 07:09:39 -0500 | Rating Details | |
| 2024-04-28 22:38:36 -0500 | Rating Details | |
| 2024-04-28 18:45:08 -0500 | Rating Details | |
| 2024-04-28 18:44:18 -0500 | Rating Details | |
| 2024-05-01 02:21:37 -0500 | Rating Details | |
| 2024-04-30 11:59:14 -0500 | Rating Details | |
| 2024-04-30 07:05:09 -0500 | Rating Details | |
| 2024-04-30 02:14:45 -0500 | Rating Details | |
| 2024-04-29 18:58:52 -0500 | Rating Details | |
| 2024-04-29 17:51:41 -0500 | Rating Details | |
| 2024-04-29 17:40:13 -0500 | Rating Details | |
| 2024-04-29 09:25:53 -0500 | Rating Details | |
| 2024-04-29 08:09:57 -0500 | Rating Details | |
| 2024-04-29 07:52:27 -0500 | Rating Details | |
| 2024-04-29 07:11:14 -0500 | Rating Details | |
| 2024-04-29 07:09:43 -0500 | Rating Details | |
| 2024-04-29 07:05:32 -0500 | Rating Details | |
| 2024-04-29 07:05:19 -0500 | Rating Details | |
| 2024-04-29 02:01:56 -0500 | Rating Details | |
| 2024-05-01 00:25:45 -0500 | Rating Details | |
| 2024-04-30 17:46:39 -0500 | Rating Details | |
| 2024-04-29 22:16:26 -0500 | Rating Details | |
| 2024-04-29 18:51:27 -0500 | Rating Details | |
| 2024-04-29 18:31:05 -0500 | Rating Details | |
| 2024-04-29 18:23:22 -0500 | Rating Details | |
| 2024-04-29 10:00:11 -0500 | Rating Details | |
| 2024-04-29 09:13:57 -0500 | Rating Details | |
| 2024-04-29 07:25:51 -0500 | Rating Details | |
| 2024-04-29 07:11:36 -0500 | Rating Details | |
| 2024-04-29 07:08:19 -0500 | Rating Details | |
| 2024-04-29 06:59:53 -0500 | Rating Details | |
| 2024-05-03 07:26:35 -0500 | Rating Details | |
| 2024-05-03 06:43:55 -0500 | Rating Details | |
| 2024-05-03 06:39:54 -0500 | Rating Details | |
| 2024-05-03 06:08:10 -0500 | Rating Details | |
| 2024-05-03 06:42:21 -0500 | Rating Details | |
| 2024-05-03 06:19:54 -0500 | Rating Details | |
| 2024-04-29 16:53:46 -0500 | Rating Details | |
| 2024-05-03 07:18:47 -0500 | Rating Details | |
| 2024-05-03 07:13:13 -0500 | Rating Details | |
| 2024-05-03 06:53:39 -0500 | Rating Details | |
| 2024-05-03 06:07:17 -0500 | Rating Details | |
| 2024-04-30 11:20:38 -0500 | Rating Details | |
| 2024-04-30 04:10:36 -0500 | Rating Details | |
| 2024-04-29 18:45:59 -0500 | Rating Details | |
| 2024-04-29 18:45:09 -0500 | Rating Details | |
| 2024-04-29 12:45:52 -0500 | Rating Details | |
| 2024-04-29 11:18:14 -0500 | Rating Details | |
| 2024-04-29 10:50:26 -0500 | Rating Details | |
| 2024-04-29 09:52:39 -0500 | Rating Details | |
| 2024-04-29 07:18:24 -0500 | Rating Details | |
| 2024-04-29 07:00:53 -0500 | Rating Details | |
| 2024-04-29 05:30:13 -0500 | Rating Details | |
| 2024-04-28 20:23:36 -0500 | Rating Details | |
| 2024-04-28 18:24:08 -0500 | Rating Details | |
| 2024-04-30 04:19:28 -0500 | Rating Details | |
| 2024-04-29 14:29:28 -0500 | Rating Details | |
| 2024-04-29 18:33:17 -0500 | Rating Details | |
| 2024-04-29 08:01:04 -0500 | Rating Details | |
| 2024-04-29 07:22:13 -0500 | Rating Details | |
| 2024-04-29 06:45:24 -0500 | Rating Details |